Lung recruitment prevents collapse during laparoscopy in children: A randomised controlled trial.

BACKGROUND: Capnoperitoneum and anaesthesia impair lung aeration during laparoscopy in children. These changes can be detected and monitored at the bedside by lung ultrasound (LUS). OBJECTIVE: The aim of our study was to assess the impact of general anaesthesia and capnoperitoneum on lung collapse and the potential preventive effect of lung recruitment manoeuvres, using LUS in children undergoing laparoscopy. DESIGN: Randomised controlled study. SETTING: Single-institution study, community hospital, Mar del Plata, Argentina. PATIENTS: Forty-two children American Society of Anesthesiologists I-II aged 6 months to 7 years undergoing laparoscopy. INTERVENTIONS: All patients were studied using LUS before, during and after capnoperitoneum. Children were allocated to a control group (C-group, n=21) receiving standard protective ventilation, or to a lung recruitment manoeuvre group (RM-group) (n=21), in which lung recruitment manoeuvres were performed after recording baseline LUS images before capnoperitoneum. Loss of aeration was scored by summing a progressive grading from 0 to 3 assigned to each of 12 lung areas, based on the detection of four main ultrasound patterns: normal aeration = 0, partial loss-mild = 1, partial loss-severe = 2, total loss-consolidation = 3. MAIN OUTCOME MEASURES: Lung aeration score and atelectasis assessed by ultrasound. RESULTS: Before capnoperitoneum and recruitment manoeuvres in the treated group the two groups presented similar ultrasound scores (5.95 ±â€Š4.13 vs. 5.19 ±â€Š3.33, P = 0.5). In the RM-group, lung aeration significantly improved both during (2.71 ±â€Š2.47) and after capnoperitoneum (2.52 ±â€Š2.86), compared with the C-group (6.71 ±â€Š3.54, P < 0.001, and 8.48 ±â€Š3.22, P < 0.001, respectively). There was no statistically significant difference in the percentage of atelectasis before capnoperitoneum and recruitment manoeuvres in the RM-group (62%) and in the C-group (47%, P = 0.750). However, during capnoperitoneum, only 19% of the RM-group had atelectasis compared with 80% in the C-group (P < 0.001). CONCLUSION: The majority of children undergoing laparoscopy have anaesthesia-induced atelectasis. In most cases, lung collapse due to capnoperitoneum could have been prevented by recruitment manoeuvres followed by positive-end expiratory pressure. TRIAL REGISTRY NUMBER: NCT02824146.

Accuracy of transthoracic lung ultrasound for diagnosing anesthesia-induced atelectasis in children.

BACKGROUND: The aim of this study was to test the accuracy of lung sonography (LUS) to diagnose anesthesia-induced atelectasis in children undergoing magnetic resonance imaging (MRI). METHODS: Fifteen children with American Society of Anesthesiology's physical status classification I and aged 1 to 7 yr old were studied. Sevoflurane anesthesia was performed with the patients breathing spontaneously during the study period. After taking the reference lung MRI images, LUS was carried out using a linear probe of 6 to 12 MHz. Atelectasis was documented in MRI and LUS segmenting the chest into 12 similar anatomical regions. Images were analyzed by four blinded radiologists, two for LUS and two for MRI. The level of agreement for the diagnosis of atelectasis among observers was tested using the κ reliability index. RESULTS: Fourteen patients developed atelectasis mainly in the most dependent parts of the lungs. LUS showed 88% of sensitivity (95% CI, 74 to 96%), 89% of specificity (95% CI, 83 to 94%), and 88% of accuracy (95% CI, 83 to 92%) for the diagnosis of atelectasis taking MRI as reference. The agreement between the two radiologists for diagnosing atelectasis by MRI was very good (κ, 0.87; 95% CI, 0.72 to 1; P < 0.0001) as was the agreement between the two radiologists for detecting atelectasis by LUS (κ, 0.90; 95% CI, 0.75 to 1; P < 0.0001). MRI and LUS also showed good agreement when data from the four radiologists were pooled and examined together (κ, 0.75; 95% CI, 0.69 to 0.81; P < 0.0001). CONCLUSION: LUS is an accurate, safe, and simple bedside method for diagnosing anesthesia-induced atelectasis in children.

Seasonal variation and trends in stroke hospitalizations and mortality in a South American community hospital.

Numerous studies have reported the presence of temporal variations in biological processes. Seasonal variation (SV) in stroke has been widely studied, but little data have been published on this phenomenon in the Southern Hemisphere, and there have been no studies reported from Argentina. The goals of the present study were to describe the SV of admissions and deaths for stroke and examine trends in stroke morbidity and mortality over a 3-year period in a community hospital in Argentina. Hospital discharge reports from the electronic database of vital statistics between 1999 and 2001 were examined retrospectively. Patients who had a main discharge diagnosis of stroke (ischemic or hemorrhagic) or cerebrovascular accident (International Classification of Diseases, Ninth Revision codes 431, 432, 434, and 436) were selected. The study sample included 1382 hospitalizations by stroke (3.5% of all admissions). In-hospital mortality demonstrated a winter peak (25.5% vs 17% in summer; P = .001). The crude seasonal stroke attack rate (ischemic and hemorrhagic) was highest in winter (164 per 100,000 population; 95% CI, 159-169 per 100,000) and lowest in summer (124 per 100,000; 95% CI, 120-127 per 100,000; P = .008). Stroke admissions followed a seasonal pattern, with a winter-spring predominance (P = .008). Our data indicate a clear SV in stroke deaths and admissions in this region of Argentina. The existence of SV in stroke raises a different hypothesis about the rationale of HF admissions and provides information for the organization of care and resource allocation.

[Withdrawal of life support in the permanent vegetative state, and a dignified death]. / Suspensión de soporte vital en el estado vegetativo permanente y muerte digna.

Patient relatives often request withdrawal of life support, especially artificial nutrition and hydration, in cases of permanent vegetative or minimally conscious state, and resort to court in case of disagreement. Two recent cases of withdrawal authorized by the courts concerned, one from abroad and one from Argentina, have been controversial. Although it may appear inhuman to stop feeding and hydrating such patients, to continue it only prolongs a state of irreversible biological subsistence. Families tend to increasingly accept withdrawal if the patient status remains unchanged. However, concern persists regarding the suffering that patients may undergo from onset of withdrawal till death, even though such suffering is little conceivable in the absence of cortical function and conscience content. While doctors and the layman consider ethical to withdraw life support, a nonnegligible proportion of doctors consider that vegetative state patients, even more minimally conscious state patients, do experience hunger, thirst and pain. In some countries, like the United Kingdom, strict withdrawal criteria were proposed, together with pharmacological treatment schemes for the distress arising during the withdrawal period, even though its benefit is controversial. In Argentina, two scientific societies have publicly advocated withdrawal, but not issued formal guidelines. In any case, both "dignified death" Law 26.742 and the Civil Code consent withdrawal of life support, if accompanied by appropriate relief of clinical symptoms indicating suffering.

Es frecuente que familiares directos soliciten la suspensión de soporte vital, en particular de la hidratación y nutrición asistidas, en pacientes con estado vegetativo o de mínima conciencia permanente, y que recurran a la justicia en caso de desacuerdo. Dos casos recientes de suspensión, uno del exterior y otro argentino, autorizados por los tribunales respectivos, han sido motivo de controversia. Si bien puede parecer inhumano dejar de alimentar e hidratar, continuar haciéndolo solo prolonga un estado de supervivencia biológica irreversible. Las familias tienden a aceptar la suspensión si el paciente se mantiene sin cambios. Sin embargo, persiste preocupación por el posible sufrimiento desde la suspensión hasta la muerte, aunque el mismo es poco concebible en ausencia de función cortical y de conciencia. Si bien médicos y profanos consideran ético suspender el soporte vital, una cierta proporción de médicos considera que en el estado vegetativo, o más aún, en mínima conciencia, efectivamente se experimenta hambre, sed y dolor. En países como el Reino Unido, se han propuesto criterios de suspensión de soporte vital, y esquemas de tratamiento para el malestar durante el período de suspensión, aunque su beneficio efectivo es controvertido. La Argentina cuenta con recomendaciones de dos sociedades científicas, pero no con criterios reglamentados. Pero tanto la Ley 26.742 de "muerte digna" como el Código Civil consienten la suspensión del soporte vital en el estado vegetativo o de mínima conciencia, si se acompaña de medidas de alivio de los síntomas clínicos que puedan significar sufrimiento.

[Independent ethics committees for clinical research in Argentina. An evaluation and a system to guarantee their independence]. / Comités de ética independientes para la investigación clínica en la Argentina. Evaluación y sistema para garantizar su independencia.

The Administración Nacional de Medicamentos, Alimentos y Tecnología Médica de la República Argentina (ANMAT) requires that an independent ethics committee of sponsors and/or researchers must previously evaluate and approve all the new pharmacological research protocols carried out on human beings. However, due to the lucrative nature of the evaluation, and because the selection of the Independent Ethics Committee is carried out by the sponsors and/or researchers, the assumed autonomy of the former can be reduced to merely a relationship of "service provider-customer". The Institutional Review Board of the Mar del Plata s Community Hospital has evaluated, between 2005 and 2006, thirty three research protocols (with their corresponding information sheets for patients and informed consent forms) previously approved by a non-institutional Independent Ethics Committee. The median number of objections made by the Institutional Review Board, which prompted the previously mentioned protocols to be modified in order to be approved, was of three per protocol. In other words, the accreditation of an Independent Ethics Committee requires a system that guarantees actual independence from the sponsors and/or researchers, as well as management control mechanisms that may lead them into an eventual loss of accreditation. Several measures are proposed in order to correct the deficiencies of the present system.

[Universal ethical principles and their application in clinical drug trials]. / Los principios éticos universales y su aplicación a los ensayos clínicos de medicamentos.

Since 1931, and especially since the Nuremberg Code of 1947, an increasing number of declarations, regulations, norms, guidelines, laws, resolutions, and rules intended to create conditions for better protection of subjects participating in research studies have been published, although some have meant setbacks in the human rights of vulnerable populations. As such, violations of the dignity of experimental subjects in clinical trials continue. What researchers investigate and how the research is done, the quality and transparency of the data, and the analysis and the publication of results (of both raw and processed data) respond to the financial interests of the pharmaceutical companies, coming into permanent tension with bioethical principles and the needs of society. The active participation of civil society is necessary to make it so that pharmaceutical research, results and applications subordinate economic benefits to the protection of human rights.

Suspensión de soporte vital en el estado vegetativo permanente y muerte digna / Withdrawal of life support in the permanent vegetative state, and a dignified death

Es frecuente que familiares directos soliciten la suspensión de soporte vital, en particular de la hidratación y nutrición asistidas, en pacientes con estado vegetativo o de mínima conciencia permanente, y que recurran a la justicia en caso de desacuerdo. Dos casos recientes de suspensión, uno del exterior y otro argentino, autorizados por los tribunales respectivos, han sido motivo de controversia. Si bien puede parecer inhumano dejar de alimentar e hidratar, continuar haciéndolo solo prolonga un estado de supervivencia biológica irreversible. Las familias tienden a aceptar la suspensión si el paciente se mantiene sin cambios. Sin embargo, persiste preocupación por el posible sufrimiento desde la suspensión hasta la muerte, aunque el mismo es poco concebible en ausencia de función cortical y de conciencia. Si bien médicos y profanos consideran ético suspender el soporte vital, una cierta proporción de médicos considera que en el estado vegetativo, o más aún, en mínima conciencia, efectivamente se experimenta hambre, sed y dolor. En países como el Reino Unido, se han propuesto criterios de suspensión de soporte vital, y esquemas de tratamiento para el malestar durante el período de suspensión, aunque su beneficio efectivo es controvertido. La Argentina cuenta con recomendaciones de dos sociedades científicas, pero no con criterios reglamentados. Pero tanto la Ley 26.742 de "muerte digna" como el Código Civil consienten la suspensión del soporte vital en el estado vegetativo o de mínima conciencia, si se acompaña de medidas de alivio de los síntomas clínicos que puedan significar sufrimiento.

Patient relatives often request withdrawal of life support, especially artificial nutrition and hydration, in cases of permanent vegetative or minimally conscious state, and resort to court in case of disagreement. Two recent cases of withdrawal authorized by the courts concerned, one from abroad and one from Argentina, have been controversial. Although it may appear inhuman to stop feeding and hydrating such patients, to continue it only prolongs a state of irreversible biological subsistence. Families tend to increasingly accept withdrawal if the patient status remains unchanged. However, concern persists regarding the suffering that patients may undergo from onset of withdrawal till death, even though such suffering is little conceivable in the absence of cortical function and conscience content. While doctors and the layman consider ethical to withdraw life support, a nonnegligible proportion of doctors consider that vegetative state patients, even more minimally conscious state patients, do experience hunger, thirst and pain. In some countries, like the United Kingdom, strict withdrawal criteria were proposed, together with pharmacological treatment schemes for the distress arising during the withdrawal period, even though its benefit is controversial. In Argentina, two scientific societies have publicly advocated withdrawal, but not issued formal guidelines. In any case, both "dignified death" Law 26.742 and the Civil Code consent withdrawal of life support, if accompanied by appropriate relief of clinical symptoms indicating suffering.

Los principios éticos universales y su aplicación a los ensayos clínicos de medicamentos / Universal ethical principles and their application in clinical drug trials

Desde el año 1931 y, especialmente, desde el Código de Núremberg de 1947, un creciente número de declaraciones, regulaciones, normas, guías, leyes, resoluciones y disposiciones pretenden generar condiciones para una mejor protección de los sujetos que participan en estudios de investigación, aunque también algunas implican retrocesos en el respeto a los derechos de poblaciones vulnerables. Sin embargo, todavía no se ha podido evitar la violación de la dignidad de los sujetos de experimentación en ensayos clínicos. Lo que se investiga, cómo se investiga, la calidad y transparencia de los datos obtenidos, el análisis y la publicación de los resultados (tanto de los datos crudos como de los ya elaborados) están sometidos a la lógica del lucro, la cual presenta una tensión permanente con los principios bioéticos y las necesidades de la sociedad. Es necesario el protagonismo activo de los pueblos para que la investigación farmacológica, sus resultados y aplicaciones avancen en un rumbo que subordine el beneficio económico a la protección de los derechos humanos.

Since 1931, and especially since the Nuremberg Code of 1947, an increasing number of declarations, regulations, norms, guidelines, laws, resolutions, and rules intended to create conditions for better protection of subjects participating in research studies have been published, although some have meant setbacks in the human rights of vulnerable populations. As such, violations of the dignity of experimental subjects in clinical trials continue. What researchers investigate and how the research is done, the quality and transparency of the data, and the analysis and the publication of results (of both raw and processed data) respond to the financial interests of the pharmaceutical companies, coming into permanent tension with bioethical principles and the needs of society. The active participation of civil society is necessary to make it so that pharmaceutical research, results and applications subordinate economic benefits to the protection of human rights.

[Paroxysmal upgaze deviation syndrome]. / Síndrome de desviación paroxística de la mirada hacia arriba.

In 1988, Ouvrier and Billson described four children with a condition they termed "benign paroxysmal tonic upgaze syndrome". The clinical picture is characterized by the appearance, in the first months of life, of episodes of paroxysmal upgaze deviation of varying duration, and without alteration of consciousness. Fixation nystagmus is observed when trying to look down. Episodes disappear during sleep. The neurological examination is usually normal, except for mild ataxia. In its idiopatic way, the syndrome tends to spontaneous recovery, but secondary types with different evolution should be rule out. We report two patients, one with Down Syndrome, and we analyze clinical aspects, evolution and differential diagnosis.

Ischemic stroke related to anabolic abuse.

Anabolic-androgenic steroid (AAS) abuse increased in recent years, and it is associated with numerous adverse effects. Few reports on ischemic stroke related to anabolic steroid abuse have been published. We report a case of a 26-year-old male amateur athlete who suffered a posterior territory ischemic stroke. No abnormalities were found in angiography and echocardiography studies, neither in hemostatic profile. His only significant risk factor was nonmedical use of stanozolol, an anabolic steroid. Anabolic steroids are capable of increasing vascular tone, arterial tension, and platelet aggregation; therefore, they are prone to produce atherothrombotic phenomena. Because of young people's widespread use of anabolic steroids, physicians should be aware of this kind of complication.

Síndrome de desviación paroxística de la mirada hacia arriba / Paroxysmal upgaze deviation syndrome

En 1988, Ouvrier y Billson describieron cuatro niños con una afección que denominaron “síndrome de desviación paroxística benigna de la mirada hacia arriba”. El cuadro clínico se caracteriza por la aparición, en los primeros meses de la vida, de episodios de elevación paroxística de la mirada, de duración variable y sin alteración de la conciencia. Al intentar mirarhacia abajo se observa nistagmo de fijación. Los episodios desaparecen durante el sueño. El examen neurológico suele ser normal, excepto por leve ataxia. El síndrome tiende, en suforma idiopática, a la recuperación espontánea, pero deben descartarse formas secundarias con diferente evolución. Presentamos dos nuevos pacientes, uno de ellos con síndrome de Down, y analizamos aspectos clínicos, evolutivos y diagnósticos diferenciales.

In 1988, Ouvrier and Billson described four children with a condition they termed "benign paroxysmal tonic upgaze syndrome". The clinical picture is characterized by the appearance, in the first months of life, of episodes of paroxysmal upgaze deviation of varying duration, and without alteration of consciousness. Fixation nystagmus is observed when trying to look down. Episodes disappear during sleep. The neurological examination is usually normal, except for mild ataxia. In its idiopatic way, the syndrome tends to spontaneous recovery, but secondary types with different evolution should be rule out. We report two patients, one with Down Syndrome, and we analyze clinical aspects, evolution and differential diagnosis.

Comités de ética independientes para la investigación clínica en la Argentina: Evaluación y sistema para garantizar su independencia / Independent ethics committees for clinical research in Argentina: An evaluation and a system to guarantee their independence

La Administración Nacional de Medicamentos, Alimentos y Tecnología Médica de la República Argentina (ANMAT) exige para la ejecución de protocolos de investigación de nuevos fármacos en seres humanos, que éstos sean previamente evaluados y aprobados por un denominado comité de ética independiente de los patrocinadores e investigadores. Sin embargo, esta evaluación es lucrativa y la elección del comité de ética independiente es realizada por el patrocinador y/o investigador, lo que convierte la supuesta independencia en una relación del tipo "prestador de servicio - cliente". El Consejo de Revisión Institucional de Estudios de Investigación del Hospital Privado de Comunidad de Mar del Plata evaluó, entre los años 2005 y 2006, treinta y tres protocolos (con sus correspondientes hojas de información al paciente y consentimientos informados) aprobados previamente por un comité de ética independiente no institucional. La mediana de objeciones relevantes realizadas por este Consejo de Revisión a los mencionados protocolos, que obligaron a que sean modificados para luego ser aprobados, fue de tres por protocolo. La acreditación de los Comités de Ética Independiente exige un sistema que garantice la real independencia de éstos de los patrocinadores y/o investigadores a la vez que mecanismos de control de gestión que incluyan una eventual pérdida de la acreditación. Este trabajo propone algunas medidas concretas para corregir las deficiencias del sistema actual.

The Administración Nacional de Medicamentos, Alimentos y Tecnología Médica de la República Argentina (ANMAT) requires that an independent ethics committee of sponsors and/or researchers must previously evaluate and approve all the new pharmacological research protocols carried out on human beings. However, due to the lucrative nature of the evaluation, and because the selection of the Independent Ethics Committee is carried out by the sponsors and/or researchers, the assumed autonomy of the former can be reduced to merely a relationship of "service provider-customer". The Institutional Review Board of the Mar del Plata's Community Hospital has evaluated, between 2005 and 2006, thirty three research protocols (with their corresponding information sheets for patients and informed consent forms) previously approved by a non-institutional Independent Ethics Committee. The median number of objections made by the Institutional Review Board, which prompted the previously mentioned protocols to be modified in order to be approved, was of three per protocol. In other words, the accreditation of an Independent Ethics Committee requires a system that guarantees actual independence from the sponsors and/or researchers, as well as management control mechanisms that may lead them into an eventual loss of accreditation. Several measures are proposed in order to correct the deficiencies of the present system.

Muerte encefálico: un tema en debate / Brain death: a debated subject

Con el objeto de determinar la comprensión que en un grupo de médicos tenía respecto del significado de la expresión "muerte cerebral"y las condiciones necesarias para su reconocimiento,su relación con el diagnóstico de muerte y la conducta que adoptarían ante un dilema ético en el que está implicada la decisión de ablación de un paciente anencéfalo,se realizaron tres preguntas con respuestas múltiples que contestaron 41 facultativos.La encuesta reveló un severo desconocimiento en cuanto a la exigencias necesarias para diagnosticar la "muerte cerebral"con una sobrevaloración del electroencefalograma.Una proporción importante de profesionales no identificaron "muerte cerebral" con la muerte del paciente.Hubo una sorprendente uniformidad en la respuesta ante el dilema ético planteado con posturas opuestas a lo que las leyes y la posición predominante en la literatura han establecido a la fecha.Dada la vigencia que tiene el debate respecto del diagnóstico de muerte,fundamentalmente ante el problema de los trasplantes,la confusión que los médicos tienen en este tema,quizás constituya una de las barreras más importantes para llegar con ideas claras a la población